AMDA leadership weighs in on DEA’s telehealth medicine rules debate
By
Jessica R. Towhey
Aaron Dorman
Aug 10, 2023
The DEA may re-evaluate its rules on prescribing controlled substances via telehealth appointments, following a deluge of 38,000 public comments on the initial rulemaking.
Senate leader promises coronavirus relief this week as U.S. cases, deaths increase and senior living...
By
Lois A. Bowers
Mar 18, 2020
As coronavirus disease 2019 (COVID-19) spreads in the U.S. and senior living companies face increasing challenges, the Senate on Tuesday did not vote on a relief bill passed by the House. Senate Majority...